4.8 Article

PI3K Inhibition Activates SGK1 via a Feedback Loop to Promote Chromatin-Based Regulation of ER-Dependent Gene Expression

Journal

CELL REPORTS
Volume 27, Issue 1, Pages 294-+

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2019.02.111

Keywords

-

Categories

Funding

  1. Stand Up to Cancer (Cancer Drug Combination Convergence Team)
  2. V Foundation
  3. National Science Foundation
  4. MSK Society Scholar Prize
  5. Jane Coffin Childs Memorial Fund
  6. NIH [P30 CA008748, RO1CA190642-01A1]
  7. Breast Cancer Research Foundation
  8. Geoffrey Beene Cancer Research Center

Ask authors/readers for more resources

The PI3K pathway integrates extracellular stimuli to phosphorylate effectors such as AKT and serumand- glucocorticoid-regulated kinase (SGK1). We have previously reported that the PI3K pathway regulates estrogen receptor (ER)-dependent transcription in breast cancer through the phosphorylation of the lysine methyltransferase KMT2D by AKT. Here, we show that PI3Ka inhibition, via a negative-feedback loop, activates SGK1 to promote chromatin-based regulation of ER-dependent transcription. PI3K/AKT inhibitors activate ER, which promotes SGK1 transcription through direct binding to its promoter. Elevated SGK1, in turn, phosphorylates KMT2D, suppressing its function, leading to a loss of methylation of lysine 4 on histone H3 (H3K4) and a repressive chromatin state at ER loci to attenuate ER activity. Thus, SGK1 regulates the chromatin landscape and ER-dependent transcription via the direct phosphorylation of KMT2D. These findings reveal an ER-SGK1-KMT2D signaling circuit aimed to attenuate ER response through a role for SGK1 to program chromatin and ER transcriptional output.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available